Saturday 17 October 2026
Export STIM’s income statement to Excel — free account
Neuronetics, Inc.
STIM Healthcare Medical Devices
Neuronetics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $149.2 million, up 99.2% from fiscal 2024. In the quarter to June 2026, revenue grew 9.08%, EPS grew 66.7%, free cash flow grew 62.1% and total debt rose 10.8%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
1.89
0.06
−3.08%
Follow STIM
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | 5 | 2 | 2 | 5 | 3 | 3 | 2 | 4 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
— | — | 0.54 | (2.08) | (2.10) | (1.25) | (2.05) | (3.42) | (3.94) | (3.48) |
P/S ratio |
0.00 | 0.00 | 3.28 | 1.32 | 4.25 | 2.05 | 2.72 | 1.10 | 0.68 | 0.61 |
Altman Z″-Score (non-manufacturers) |
(23.95) | (14.75) | (0.02) | (5.01) | (8.62) | (2.21) | (6.98) | (7.73) | (9.80) | (10.38) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
— | (2.67) | (2.30) | 1.51 | (2.17) | (2.36) | (2.28) | (2.16) | (1.57) | (2.59) |
P/Operating CF |
(0.10) | (0.10) | (76.07) | (12.89) | (122.88) | (25.12) | (57.27) | 36.95 | (5.94) | 100.23 |
P/B ratio |
0.00 | 0.00 | 2.44 | 1.72 | 8.21 | 1.33 | 3.11 | 2.31 | 1.61 | 3.47 |
Price to Tangible BV |
0.00 | 0.00 | 2.44 | 1.72 | 8.21 | 1.33 | 3.11 | 2.31 | 0.00 | 0.00 |
EV/Sales |
0.00 | 0.00 | 1.97 | 0.59 | 3.93 | 0.96 | 2.17 | 1.10 | 1.34 | 0.91 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(0.20) | (0.20) | (5.05) | (1.22) | (6.82) | (1.90) | (4.61) | (2.45) | (3.23) | (6.68) |
EV/FCF |
(0.19) | (0.19) | (4.81) | (1.19) | (6.65) | (1.76) | (4.16) | (2.28) | (3.09) | (6.43) |
Quick Ratio |
1.55 | 2.79 | 8.13 | 3.00 | 4.24 | 6.63 | 2.58 | 3.96 | 1.41 | 1.68 |
Current Ratio |
1.72 | 3.09 | 8.44 | 3.19 | 4.75 | 7.34 | 2.98 | 4.73 | 1.86 | 2.02 |
Net Debt/EBITDA |
(0.36) | (0.03) | 3.91 | 1.76 | 0.73 | 2.28 | 1.07 | 0.05 | (1.09) | (1.12) |
Debt/Assets |
81.21% | 75.91% | 25.97% | 31.10% | 44.77% | 25.50% | 30.76% | 51.18% | 39.14% | 46.49% |
Debt/Equity |
(4.18) | (5.36) | 0.43 | 0.65 | 1.38 | 0.42 | 0.63 | 1.73 | 1.73 | 2.51 |
Asset Turnover |
1.07 | 1.27 | 0.68 | 0.58 | 0.55 | 0.50 | 0.51 | 0.61 | 0.58 | 1.06 |
Operating CF/Net income |
0.76 | 0.69 | 0.85 | 1.05 | 1.03 | 0.90 | 0.83 | 1.06 | 0.71 | 0.52 |
Capex/Depreciation |
(0.48) | (1.00) | (1.15) | (0.76) | (0.78) | (2.22) | (1.98) | (1.18) | (0.71) | (0.23) |
Interest Coverage |
(5.09) | (4.85) | (5.38) | (7.31) | (4.93) | (6.86) | (8.26) | (5.63) | (4.74) | (3.74) |
| 6.08% | 8.69% | 39.63% | (48.86%) | (74.86%) | (56.37%) | (52.25%) | (66.17%) | (132.47%) | (134.39%) | |
| (35.25%) | (50.39%) | (30.90%) | (26.75%) | (30.70%) | (28.37%) | (28.79%) | (25.95%) | (34.05%) | (27.61%) | |
ROIC |
0.00% | 0.00% | 0.00% | (697.81%) | (141.37%) | (69.35%) | (103.82%) | (58.06%) | (32.11%) | (34.06%) |
Return on Tangible Assets |
(100.21%) | (60.90%) | (23.56%) | (46.95%) | (52.73%) | (30.93%) | (55.00%) | (39.73%) | (132.05%) | (109.87%) |
Average Days of Receivables |
38.14 | 38.52 | 38.87 | 38.27 | 53.11 | 51.34 | 77.37 | 91.26 | 118.36 | 41.34 |
Research and Development Expense of Revenue |
24.02% | 19.63% | 15.60% | 21.94% | 18.68% | 14.32% | 14.32% | 13.34% | 17.05% | 4.41% |
Selling, General and Administrative Expense of Revenue |
83.91% | 90.20% | 98.40% | 96.48% | 103.16% | 114.44% | 115.78% | 101.96% | 101.42% | 65.14% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.27 | 0.30 |
Share Based Compensation of Revenue |
0.47% | 1.23% | 3.30% | 5.48% | 8.94% | 14.23% | 13.41% | 10.26% | 7.48% | 4.59% |
Graham Net Nets |
28.17 | 28.17 | 0.40 | 0.44 | 0.06 | 0.52 | 0.22 | 0.15 | (1.00) | (0.59) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(43.06%) | (43.06%) | (287.15%) | (35.41%) | (13.14%) | (26.91%) | (20.91%) | (38.91%) | (85.09%) | (42.75%) |
Free Cash Flow Yield |
(2,499.02%) | (2,499.02%) | (12.48%) | (37.92%) | (13.92%) | (26.70%) | (19.16%) | (43.66%) | (63.54%) | (23.27%) |
Revenue per Share |
234.44 | 217.38 | 5.90 | 3.41 | 2.61 | 2.17 | 2.42 | 2.49 | 2.36 | 2.26 |
Operating CF per Share |
(58.50) | (59.91) | (2.30) | (1.66) | (1.51) | (1.10) | (1.14) | (1.12) | (0.98) | (0.31) |
Capex per Share |
(2.22) | (3.19) | (0.11) | (0.04) | (0.04) | (0.09) | (0.12) | (0.08) | (0.05) | (0.01) |
Free Cash Flow per Share |
(60.72) | (63.11) | (2.41) | (1.70) | (1.55) | (1.19) | (1.26) | (1.20) | (1.02) | (0.32) |
Cash per Share |
116.71 | 156.70 | 11.69 | 4.17 | 2.70 | 3.78 | 2.67 | 2.11 | 0.62 | 0.52 |
Shareholders Equity per Share |
(32.97) | (29.66) | 7.94 | 2.60 | 1.35 | 3.34 | 2.12 | 1.19 | 1.00 | 0.40 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(32.97) | (29.66) | 7.94 | 2.60 | 1.35 | 3.34 | 2.12 | 1.19 | 1.00 | 0.40 |
Free Cash Flow |
(8.86) | (11.74) | (21.60) | (31.29) | (29.12) | (30.34) | (34.01) | (34.41) | (32.46) | (21.17) |
Working Capital |
9.58 | 25.01 | 100.91 | 60.76 | 51.33 | 99.63 | 65.57 | 73.98 | 26.86 | 31.03 |
Capital Expenditures |
(0.32) | (0.59) | (1.01) | (0.81) | (0.73) | (2.35) | (3.27) | (2.37) | (1.47) | (0.80) |
Net Current Asset Value |
(6.69) | (7.45) | 68.49 | 36.14 | 11.85 | 59.28 | 38.95 | 12.15 | (50.98) | (53.76) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.04 | 0.05 | 0.03 | 0.02 | 0.01 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.41 | 0.44 | 0.64 | 0.96 | 1.29 | 0.87 | 0.83 | 1.00 | 0.33 | 0.78 |
Cash ROIC |
(27.39%) | (22.07%) | (10.49%) | (20.11%) | (26.10%) | (13.95%) | (20.62%) | (22.33%) | (30.45%) | (16.75%) |
Accounts Receivable Turnover |
8.73 | 10.31 | 10.68 | 10.28 | 7.17 | 7.40 | 6.04 | 4.51 | 3.56 | 7.24 |
Accounts Payable Turnover |
3.31 | 4.82 | 3.97 | 3.67 | 2.76 | 2.90 | 4.60 | 5.47 | 2.62 | 7.05 |
Inventory Turnover |
3.18 | 4.63 | 5.08 | 5.91 | 3.56 | 2.27 | 2.00 | 2.31 | 3.36 | 17.92 |
Average Days of Payables |
81.74 | 95.23 | 110.14 | 109.70 | 118.43 | 134.66 | 57.36 | 88.30 | 195.05 | 51.01 |
Days of Inventory on Hand |
93.48 | 93.52 | 71.32 | 65.82 | 117.52 | 205.57 | 209.79 | 150.38 | 74.80 | 20.55 |
Average Receivables |
3.92 | 3.92 | 4.94 | 6.09 | 6.87 | 7.47 | 10.80 | 15.83 | 21.06 | 20.59 |
Average Payables |
2.00 | 2.00 | 3.13 | 4.19 | 4.19 | 4.02 | 3.37 | 3.59 | 7.91 | 10.91 |
Average Inventory |
2.08 | 2.08 | 2.45 | 2.60 | 3.25 | 5.14 | 7.73 | 8.50 | 6.17 | 4.29 |
Average Assets |
31.87 | 31.87 | 77.98 | 108.60 | 89.41 | 109.94 | 129.05 | 116.36 | 128.37 | 141.23 |
Average Common Equity |
(184.89) | (184.89) | (60.80) | 59.45 | 36.67 | 55.33 | 71.12 | 45.63 | 32.99 | 29.02 |
Columns are period end dates